Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Greece Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20081
20111
20141
20181
20193
20221
20232
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting6
Active, not recruiting3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
GlaxoSmithKline3
Eli Lilly and Company2
Sanofi2
United Therapeutics2
Alnylam Pharmaceuticals1
AstraZeneca1
Boehringer Ingelheim1
CSL Behring1
Montreal Heart Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases20
Diabetes Mellitus, Type 25
Hypertension5
Myocardial Infarction5
Stroke5
Atherosclerosis4
Heart Diseases4
Coronary Artery Disease3
Dyslipidemias3
Heart Failure3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.